Roundabout Theatre Company's brings its production of Sanaz Toossi's Pulitzer Prize-winning play, English, directed by Knud Adams, to Broadway! The show officially opens tonight at the Todd ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 36.07% higher than today’s price of $756.99.

The 49-year-old is set to appear in court on Friday, January 17. Bell is the recipient of the 2019 Pulitzer Prize for Editorial Cartooning, the 2016 Berryman Award for Editorial Cartooning ...

A Trump-bashing, Pulitzer Prize-winning political cartoonist — whose illustrations have been published by the Washington Post, New Yorker and Los Angeles Times — was arrested for possession of ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her Endpoints News story about the case. Lilly’s lawsuit ...

Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall Street expectations. The ...

(AP Photo/Richard Drew) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] NEW YORK (AP) — Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops ...

Eli Lilly and Co. LLY Eli Lilly’s shares fell 6.59%, closing at $744.91. The stock had an intraday high of $784.23 and a low of $729, with a 52-week range of $612.7 to $972.53. The company ...